Institut for Forretningsudvikling og Teknologi

Key differences and similarities in ways of managing and supporting radical pharmaceutical front end innovation: A case study of the pharmaceutical industry

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisTidsskriftartikelForskningpeer review

ABSTRACT
The purpose of this paper is to explore how Front End Innovation (FEI) is supported and managed among companies of different nationality within the context of biotech and pharmaceutical R&D. The present study is carried out in order to contribute to the development of a clearer understanding of active facilitation of innovation management and front end innovation in theory and in practice across international borders. I aim to show how different aspects of biotech and Pharma and nationality affect the way innovation management and FEI is supported within organisations. This is examined through an in-depth case study of the Danish pharmaceutical company, H. Lundbeck A/S, and a comparative study including seven European and American biotech and pharmaceutical companies. The findings from the study reveal a number of similarities and differences in innovation management and FEI support among the different companies and present propositions of important aspects to consider in facilitation of FEI in general and in multinational pharmaceutical and biotech companies. In addition, proposals are made for a global study of innovation management and FEI support including Chinese and other Asian pharmaceutical companies, which represent a growing market. The value added and the contribution of this article to the existing FEI literature is therefore in the specificity of the empirical setting in which the issue is investigated.
OriginalsprogEngelsk
Artikelnummer1550011
TidsskriftInternational Journal of Innovation Management
Vol/bind19
Nummer1
Antal sider25
ISSN1363-9196
DOI
StatusUdgivet - 2015
Eksternt udgivetJa

Se relationer på Aarhus Universitet Citationsformater

ID: 93496299